Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Veterinary Dermatology

Volumn 24, Issue 5, 2013, Pages

  Cosgrove, Sallie B ^a   Wren, Jody A ^a   Cleaver, Dawn M ^a   Martin, David D ^a   Walsh, Kelly F ^a   Harfst, Jessica A ^a   Follis, Stacey L ^a   King, Vickie L ^a   Boucher, Joseph F ^a   Stegemann, Michael R ^b  

^a ZOETIS   (United States)

^b Zoetis Veterinary Medicine Research and Development   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

DERMATOLOGICAL AGENT; OCLACITINIB; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HYPERSENSITIVITY; MALE; PATHOLOGY; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; DERMATITIS; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; FEMALE; HYPERSENSITIVITY; MALE; PRURITUS; PYRIMIDINES; SULFONAMIDES;

EID: 84883786468     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12047     Document Type: Article

References (33)

1. ® Pet Insurance website. Top 10 pet medical conditions of 2010. Available at: http://press.petinsurance.com/pressroom/02222011Pet_Conditions_2010.aspx. Accessed Dec 28, 2012.
2. Hill PB, Lo A, Eden CAN et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 2006; 158: 533-539.
3. Nuttall T, McKeever PJ, Harvey RG. Pruritic dermatitis. In: Beynon P, ed. A Colour Handbook of Skin Diseases of the Dog and Cat. 2nd edn. London: Manson Publishing, 2009; 35-37.
4. Olivry T, Bisikova P. A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Vet Dermatol 2013; 24: 97-117, e25-e26.
5. Bloom P. Nonsteroidal, nonimmunosuppressive therapies for pruritus. Vet Clin North Am: Small Anim Pract 2013; 43: 173-187.
6. Scott DW, Miller WH, Griffin CE. Dermatologic therapy. In: Muller and Kirk's Small Animal Dermatology, 6th edition. Philadelphia: W.B. Saunders Co., 2001; 207-274.
7. Steinhoff M, Bienenstock J, Schmelz M et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006; 126: 1705-1718.
8. Metz M, Ständer S. Chronic pruritus - pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010; 24: 1249-1260.
9. Plumb DC. Glucocorticoid agents, general information. Veterinary drug handbook. 4th edn. Ames, IA: Blackwell Publishing; 2002; 387-389.
10. Nuttall T, Mueller R, Bensignor E et al. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial. Vet Dermatol 2009; 20: 191-198.
11. Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003; 14: 121-146.
12. Scott DW, Miller WH, Griffin CE. Skin immune system and allergic skin diseases. In: Muller and Kirk's Small Animal Dermatology, 6th edition. Philadelphia, PA: W.B. Saunders Co., 2001; 543-666.
13. Gonzales AJ, Humphrey WR, Messamore JE et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013; 24: 48-53, e11-e12.
14. Fleck T, Humphrey W, Coscarelli E et al. Comparison of the janus kinase (JAK) inhibitor, oclacitinib, and prednisolone in canine models of pruritus. Vet Dermatol 2012; 23(Suppl 1): 38 (abstract).
15. Carmi-Levy I, Homey B, Soumelis V. A modular view of cytokine networks in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 245-253.
16. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 2006; 6: 384-389.
17. Felsburg PJ. Overview of immune system development in the dog: comparison with humans. Hum Exp Toxicol 2002; 21: 487-492.
18. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 482: 20059-20063.
19. International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), Good Clinical Practice Website. Available at: http://www.vichsec.org/en/topics.htm. Accessed Dec 28, 2012.
20. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol 2007; 18: 301-308.
21. Collard WT, Hummel BD, Malpas PB et al. Single and multiple dose pharmacokinetics of oclacitinib maleate in the dog. In: Proceedings of the American Academy of Veterinary Pharmacology and Therapeutics, Biennial Meeting. Potomac, MD, USA. 2013 (Abstract #23).
22. Rybnicek J, Lau-Gillard PJ, Harvey R et al. Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 2009; 20: 115-122.
23. Hill P, Rybnicek J, Lau-Gillard P. Correlation between pruritus score and grossly visible erythema in dogs. Vet Dermatol 2010; 21: 450-455.
24. Olivry T, Rivierre C, Jackson HA et al. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Vet Dermatol 2002; 13: 77-87.
25. Schmidt V, McEwan N, Volk A et al. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis. Vet Dermatol 2010; 21: 96-105.
26. Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Vet Dermatol 2003; 14: 11-22.
27. Miller WH, Scott DW, Wellington JR. A clinical trial on the efficacy of clemastine in the management of allergic pruritus in dogs. Can Vet J 1993; 34: 25-27.
28. Hill PB, Hoare J, Lau-Gillard P et al. Pilot study of the effect of individualised homeopathy on the pruritus associated with atopic dermatitis in dogs. Vet Rec 2009; 164: 364-370.
29. Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol 2010; 21: 233-248.
30. Olivry T, Mueller RS, The International Task Force on Canine Atopic Dermatitis. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003; 14: 121-146.
31. Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010; 21: 4-22.
32. Wheeler DW, Civil J, Payne-Johnson M et al. Oclacitinib for the treatment of pruritus and lesions associated with canine flea-allergic dermatitis. Vet Dermatol 2012; 23(Suppl 1): 38-39 (abstract).
33. Cosgrove SB, Wren JA, Cleaver DM et al. Efficacy and safety of oclacitinib compared to placebo for the control of atopic dermatitis in client-owned dogs. Vet Dermatol 2013; 24: 295 (abstract).